I posted this in another thread but thought it was worth creating a new thread for. Just found this link to a new interview with Roger Aston discussing the Phase 2 Canine trial. He discusses the trial, clarifies 'stable disease', the Elanco option, human trials and more. Very much worth a watch. Brings me more confidence to hear it from him personally.
https://www.youtube.com/watch?v=73rIH2s5Tbg&feature=youtu.be
If link doesn't work, type "PharmAust (ASX PAA) Q&A" into YouTube by the channel "TechInvest Magazine"
Roger Aston Interview May 2020
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.010(4.88%) |
Mkt cap ! $77.20M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.8¢ | $288.9K | 1.502M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 624174 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 394 | 2 |
View Market Depth
| Last trade - 13.35pm 27/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |